Edward Price, President & CEO, SEQENS N.A. and member of the Bulk Pharmaceuticals Task Force, an affiliate of SOCMA testified to the Subcommittee on Health of the Committee on Energy and Commerce on October 30.
Categories for Affiliates
Edward Price, President and CEO, SEQENS N.A. and a member of SOCMA’s Bulk Pharmaceutical Task Force, today called for reasonable regulations and increased collaboration between stakeholders during testimony before the House Committee on Energy & Commerce hearing on Pharmaceutical Supply Chains in a Global Economy.
Arlington, VA - Innovation and commercialization of the next generation of opportunities in single-use processing and cell therapies is a key focus of the Bio-Process Systems Alliance (BPSA) 9th Annual International Single-Use Summit, July 22-24, at the Four Seasons Hotel in Washington, DC.
BPSA Awards Training and Education Grants to 3 University-Based Centers for Bio-Processing Skills Enhancements
Arlington, VA - The Bio-Process Systems Alliance (BPSA), an international industry association of the single-use bio-processing industry, is pleased to announce the 2019 recipients of the Jerold Martin Legacy Scholarship Fund.
North Little Rock, AR — La Petite Roche Technologies, a subsidiary of Safe Foods Corporation, has announced that David Fortune will be joining the company as its Vice President. David has over 40 years of management experience with industry leading companies, including manufacturers of furniture, consumer electronics, industrial goods, oil & gas, and chemicals. Prior to joining La Petite Roche Technologies, David served as Plant Manager for Thomas & Betts, as Vice President of Sales & Business Development for KMCO LLC and as a Director of Business Development for Athlon Solutions/Halliburton.
ARLINGTON, VA – The Bio-Process Systems Alliance, the primary international industry association for single-use bio-processing, is pleased to announce the release of its latest white paper, The Role of Single-Use Polymeric Solutions in Enabling Cell and Gene Therapy Production, compiled by a select committee of experts in the fields of single-use technology (SUT) and cell and gene therapies.
After almost three weeks, the government shutdown is having a ripple affect on the Food and Drug Administration’s (FDA) submission of Generic Drug User Fee Act (GDUFA) and other pharmaceutical supply chain user fee programs overseen by the Agency.
SOCMA’s BPTF Executive Director Shares Perspective on API Supply Issues, Impact on PharmaChem Sector FDA Workshop addresses underlying issues related... View Article
SOCMA’s BPTF Executive Director Shares Perspective on API Supply Issues, Impact on PharmaChem Sector
ARLINGTON, VA – John DiLoreto, Executive Director of the Bulk Pharmaceuticals Task Force and advisor to SOCMA’s PharmaChem Sector, delivered a fresh perspective on the pharmaceutical supply problem as a trickle-down effect of multiple factors within the fine and specialty chemical sector during a panel discussion on Manufacturing and Supply Challenges in Washington, D.C.
ARLINGTON, VA – John DiLoreto, Executive Director of the Bulk Pharmaceuticals Task Forceand advisor to SOCMA’s PharmaChem Sector, will participate in a panel discussion about Manufacturing and Supply Challenges at a U.S. Food & Drug Administration event sponsored by Duke Margolis Center for Health Policy.